ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
General Proximity
General Proximity is a seed-stage startup seeking a medicinal chemist to pioneer a novel class of induced proximity medicines. The role involves designing and optimizing bifunctional molecules, supervising synthetic efforts, and collaborating on drug discovery technology development.
General Proximity pioneers next‑generation medicines that control biological processes by precisely manipulating molecular proximity. Using proximity‑driven therapeutic approaches and platform technologies, they design treatments to modulate cellular function with greater specificity and control. The company aims to redefine the future of medicine by applying these modalities across disease areas to address unmet medical needs for all humankind.
PR NewswireGeneral Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform
Nov 13, 2025
Pharmaceutical TechnologyGeneral Proximity and Daiichi Sankyo collaborate on oncology
Nov 14, 2025
Longevity.TechnologyDoes control of proximity equal control of biology?
Apr 15, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for General Proximity.
General Proximity didn’t post a salary, so this is our estimate from similar listings.
PR NewswireGeneral Proximity De-Stealths with $16M to Pioneer Next-Gen Induced Proximity Medicines for 'Undruggable' Targets
Jan 3, 2025
AIDD Medicinal Chemist
ASTARPRD
Associate or Full Professor, Medicinal Chemistry
Indiana University
Senior Scientist, Medicinal Chemistry
Calico
Staff Scientist II - Medicinal Chemistry
8a7882525b6027b0015b692822e001ab
Medicinal Chemistry Project Leader
Arvinas
Senior Scientist - Medicinal Chemistry
lifelancer
